Glucosylation endows nanoparticles with TLR4 agonist capability to trigger macrophage polarization and augment antitumor immunity.
Liu L, Fu S, Zhu W, Cai Z, Cao Y, Huang Y, Yang L, Fu X, Jin R, Xia C, Zhang Y, Lui S, Gong Q, Song B, Wen L, Anderson JM, Ai H.
Liu L, et al. Among authors: yang l.
Biomaterials. 2024 Jan;304:122424. doi: 10.1016/j.biomaterials.2023.122424. Epub 2023 Dec 11.
Biomaterials. 2024.
PMID: 38103347